A US FDA advisory committee endorsed the efficacy and safety of [60 Degrees Pharmaceuticals LLC]’s Arakoda (tafenoquine) for malaria prevention in adults but is counting on postmarketing studies to provide clarity on questions left unanswered by the “patchwork” of small trials supporting the application.
Additional studies are needed after approval to assess efficacy in adults over age 65 years, pediatric populations and heavier individuals,...





